The Equine Healthcare Market is expected to foresee significant growth. North America leads the growth!
- Vikas Kumar
- January 14, 2023
- HEALTHCARE, NEWS
- Asia Equine Healthcare Market, Equine Healthcare, Equine Healthcare Market, Equine Healthcare Market analysis, Equine Healthcare Market forecast, Equine Healthcare Market growth, Equine Healthcare Market share, Equine Healthcare Market size, Equine Healthcare Market trend, Europe Equine Healthcare Market, Middle east Equine Healthcare Market, US Equine Healthcare Market
- 0 Comments
The global equine healthcare market is expected to register a CAGR of approx. 5% over the period of 2022-2028. Equine health is an important aspect of a horse’s overall well-being. Maintaining racehorse health is critical because proper management can reduce the occurrence of many disease conditions. As horses interact with their surroundings, they rely on health concerns to maintain proper performance and stability. Understanding the health of the horse can aid in its overall well-being. Routine veterinary care for vaccinations, parasite control, dental care; grooming and hoof care; and protection are all part of horse care. Global equine healthcare is rising due to the increasing equine population around the globe. For instance, according to BLM.gov, the total number of equine populations in U.S. are 82,384 in horses 64,604 and burros 17,780 in March 2022. Owing to the glaring statistics, the increasing number of horses suffering from diseases is leading to the growing demand for equine healthcare and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the equine healthcare market is anticipated to grow on account of the increase in animal healthcare spending and the rise in the advancement of equine healthcare products. However, one of the major factors which restricted market growth (during the COVID pandemic) is rising unemployment rates, as, the lockdown measures led to equine welfare crisis concerns all over the world. However, the situation has improved post-COVID, and the market is anticipated to show promising growth in the coming years.
Request for Sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=32142
Based on the product, the equine healthcare market is segmented into drug, vaccines, medicinal feed additives, diagnostics, and others. The drug segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to a surge in awareness towards effective & advanced drugs and vaccines and a rise in number of cases of equine diseases.
Based on the application, the market is fragmented into parasite control, influenza, tetanus, west nile virus, equine infectious anemia, equine herpes virus, and others. The parasite control segment grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. There are numerous ways to administer parasiticides, including sprays, collars, oral solutions, gels, and spot-on treatments. Ectoparasiticides are used to treat external parasites, while endoparasiticides treat internal parasites. They are also suitable for use topically, orally, or intravenously.
Based on the distribution channel, the market is bifurcated into veterinary hospitals and clinics, and retail pharmacies and drug stores. The veterinary hospitals and clinics segment grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. An increase in the number of veterinary hospitals, clinics, and veterinarians due to an increase in equine diseases and the equine population is likely to aid the segment growth.
For a detailed analysis of the Global Equine Healthcare Market browse through- https://univdatos.com/report/equine-healthcare-market/
For a better understanding of the market adoption of equine healthcare, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the equine healthcare industry owing to the ease of availability of the products and services across developing countries, the rise in animal health expenditure, and the increase in the population of equine. For instance, according to the FAO, there were around 10.56 million horses in the U.S. in 2021, and about 10.96 million horses in the North American region.
Some of the major players operating in the market include Merck & Co., Inc, Zoetis, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Hallmarq Veterinary Imaging, ESAOTE SPA, Vetoquinol S.A, Thermo Fisher Scientific Inc., Bayer AG, Elanco.
Global Equine healthcare Market Segmentation
Market Insight, by Products
- Drug
- Vaccines
- Medicinal Feed Additives
- Diagnostics
- Others
Market Insight, by Application
- Parasite Control
- Influenza
- Tetanus
- West Nile Virus
- Equine Infectious Anemia
- Equine Herpes Virus
- Other diseases
Market Insight, by End-Users
- Veterinary Hospitals and Clinics
- Retail pharmacies and Drug Stores
Market Insight, by Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- France
- Germany
- Italy
- Spain
- U.K
- Rest of Europe
- Asia-Pacific
- China
- India
- Australia
- Japan
- Rest of Asia-Pacific
- Rest of World
Top Company Profiles
- Merck & Co., Inc
- Zoetis
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
- Hallmarq Veterinary Imaging
- ESAOTE SPA
- Vetoquinol S.A
- Thermo Fisher Scientific Inc.
- Bayer AG
- Elanco
